WASHINGTON, DC - 100 fewer cures. Storm clouds on the horizon. 88% reduction in number of drugs brought to market in California alone. This is Speaker Pelosi’s drug pricing scheme, and it will have devastating effects for Americans relying on innovative new medicines for hope.
Lower costs and more cures are not mutually exclusive principles. There are bipartisan bills we could pass into law right now to achieve both goals. That is why, as The Washington Post outlined this morning, Republicans will soon introduce legislation to lower costs at the drug counter for patients and seniors.
The upcoming plan includes policy that could earn bipartisan, bicameral support, if only Democrats would drop H.R. 3 and work together with Republicans. As outlined in a seven-part video series from Energy and Commerce Republican Leader Greg Walden (R-OR) and Rep. Dan Crenshaw (R-TX), Speaker Pelosi’s partisan plan for fewer cures is not the answer the American people are searching for.
FULL VIDEO SERIES
Watch each video in the #FewerCures Facts series using the links below:
1. “Impact on Cures"
2. “Tax on Cures & Impact on Innovators"
3. “Debunking the Dems’ VA Talking Point"
4. “Debunking the Dems’ Research Talking Point"
5. “GOP Solutions: Insulin Savings"
6. “GOP Solutions: The Path Forward"
7. “GOP Solutions: Unleashing American Innovation"
